• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[人类干细胞研究的伦理依据。德国干细胞研究中央伦理委员会的观点]

[Ethical justification for human stem cell research. The view of the German Central Ethics Committee for Stem Cell Research].

作者信息

Siep L

机构信息

Westfälische Wilhelms-Universität, Münster, BRD.

出版信息

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):950-3. doi: 10.1007/s00103-008-0620-8.

DOI:10.1007/s00103-008-0620-8
PMID:18769901
Abstract

According to the German Stem Cell Act the Central Ethics Committee for Stem Cell Research (ZES) advices the competent authority (Robert Koch Institute) as to whether an application to import human embryonic stem-cells for research is "ethically justifiable" ("ethisch vertretbar"). The law does indeed specify some conditions of this justification, but without precisely defining them. This article clarifies the committee's understanding of ethically justifiable research. It deals with misunderstandings of the law and problems involved in its application.

摘要

根据德国《干细胞法案》，中央干细胞研究伦理委员会（ZES）就进口人类胚胎干细胞用于研究的申请是否“在伦理上具有正当性”（“ethisch vertretbar”）向主管当局（罗伯特·科赫研究所）提供建议。该法律确实规定了这种正当性的一些条件，但并未对其进行精确界定。本文阐明了委员会对具有伦理正当性研究的理解。它探讨了对该法律的误解以及应用中所涉及的问题。

相似文献

1
[Ethical justification for human stem cell research. The view of the German Central Ethics Committee for Stem Cell Research].[人类干细胞研究的伦理依据。德国干细胞研究中央伦理委员会的观点]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):950-3. doi: 10.1007/s00103-008-0620-8.
2
[The criteria of high priority, adequacy of research in the animal and adult human models, and the absence of an alternative according to section 5 of the German Stem Cell Act: the ethical perspective].[高优先级标准、动物和成年人类模型中的研究充分性以及根据德国干细胞法案第5条不存在替代方案：伦理视角]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):954-60. doi: 10.1007/s00103-008-0621-7.
3
[Ethical evaluation of human embryonic stem cell research in Germany. Five years experiences of the German Central Ethics Committee for Stem Cell Research].[德国人类胚胎干细胞研究的伦理评估。德国干细胞研究中央伦理委员会的五年经验]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):947-9. doi: 10.1007/s00103-008-0679-2.
4
[Human embryonic stem cell research in Germany. The scientific reviewing of applications for the import and use of human embryonic stem cells].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):961-4. doi: 10.1007/s00103-008-0622-6.
5
Donating embryos for human embryonic stem cell (hESC) research: a committee opinion.捐赠胚胎用于人类胚胎干细胞（hESC）研究：委员会意见。
Fertil Steril. 2013 Oct;100(4):935-9. doi: 10.1016/j.fertnstert.2013.08.038.
6
[Activities report of the Central Ethics Commission on Stem Cell Research (ZES): Fifth Report after taking effect of the Stem Cell Law (StZG) for the time period from 12/1/2006 to 11/30/2007].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Apr;51(4):472-6. doi: 10.1007/s00103-008-0518-5.
7
[Annual report of the German Central Ethics Committee for Stem Cell Research : Seventh report after enactment of the Stem Cell Act for the reporting period 1 December 2008 to 30 November 2009].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Jun;53(6):623-8. doi: 10.1007/s00103-010-1071-6.
8
[From basic research to the clinic. Regulations for preclinical and clinical studies with stem cells].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):973-9. doi: 10.1007/s00103-008-0624-4.
9
Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards.人类干细胞研究的责任监督：加利福尼亚再生医学研究所的医学与伦理标准
PLoS Med. 2007 May;4(5):e114. doi: 10.1371/journal.pmed.0040114.
10
[Yes to research, no to utilization? Medical, pharmacological and toxicological utilization of human embryonic stem cells from an ethical point of view].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Sep;51(9):965-72. doi: 10.1007/s00103-008-0623-5.